Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
KTCC nice
watch KTCC zab it is headed over $3 imo
KTCC headed over $2
KTCC extremely bullish chart this stock is headed over $2 next week, still holding some CPSL for earnings and RRI with an $8 target have a good weekend all
agree 100% KTCC a monster doubler next two weeks look at that ultra bullish chart higher highs higher lows every day
KTCC going over $3 what a monster chart one huge cup with handle techies might find it too late
beat on non-gaap eps by 900% last qtr
KOP what a day, should run again tomorrow
beat on eps by .23
KOP still exploding higher Tony, KTCC next
GAPPER = KOP
(.23 eps beat and upside surprise)
KTCC breaking out of a pennant today $2+ coming on chart = Current BV is $4.96
KTCC now 1.50 higher high
look at that pennant!
JVA yes just flipped it for a small gain, watch KTCC if it breaks through $1.47 perfect bullish pennant the last few sessions the bv alone on it is near $5
3.25 JVA strong all day after mid morning reversal, may be nice follow through tomorrow
1.34 KTCC crazy cheap now has a BV of 4.966 after last q & chart is setting up for another huge pop -- stock to watch --
JAVO making a 3 drives up move to .70
coffee stocks at/near new highs DDRX JAVO CBOU PEET GMCR
CPSL blowing up +54% watch the $1-$2 small caps if there are any left
CPSL going wild +41%
DDR nice and another one that you may want to watch is FCH
radar JAVO.OB a .34 coffee retailer with over 10,000 new locations this little stock could explode soon on sectorwide GMCR momo, right now in a nice base:
**Javo Beverage Company Announces Record 2008 Year-End Financial Results
Revenue Grows 55% Compared to 2007
Dispensed Beverage Locations Grow 134% to 10,084
Gross Profit Up to $8.2 Million**
ABR thanks, now over $3 like the gift that keeps on giving I had this one at $1.20
KTCC consolidating then next leg to $2 they beat earnings by 900% without one time charges
GMCR speechless, sectorwide coffee momo kicking in watch DDRX CBOU JVA JAVO.OB PEET
ABR gapping up again near 3% again this real estate REIT has been catching a strong bid, already doubled in less then a month
KTCC gapping up 9% on strong earnings
http://finance.yahoo.com/news/Key-Tronic-Corporation-bw-15059204.html?.v=1
me too watch little KTCC today they had blowout earnings after hours
CTT COIN exploding
GAPPER = CTT (multiple insiders buying)
http://www.insidercow.com/
CTT EFUT COIN gappers!!!
CTT news --
Competitive Technologies Signs Agreement for Sales of Pain Therapy Medical Device
Therapy Medical Device to Selected U.S. Government Agencies
FAIRFIELD, Conn., April 22, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that it has signed an agreement with Northville, MI-based Native Energy & Economic Development LLC (Native Energy) granting them exclusive sales rights for selected U.S. Government agencies, including the Department of Veteran's Affairs (VA), the Department of Defense (DOD), and the Indian Health Service (IHS), for CTT's pain therapy medical device. The device, a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs, has FDA 510(k) status for sales in the U.S. CTT continues to review and select distributors representing other U.S. and global markets, including Europe, Asia and Latin America. CTT has exclusive worldwide rights to this device.
"Native Energy provides CTT with an established partner to reach U.S. government agencies that include the wounded warrior and the native American population in their healthcare programs," said John B. Nano, CTT's Chairman, President and CEO. "We believe that Native Energy's experience, contacts and knowledge of these important segments of the population will greatly facilitate sales of the device."
Steven J. Morello, founder of Native Energy, commented, "We welcome this opportunity to improve healthcare available to our veterans and Native Americans, by providing an alternative to harmful drug protocols for pain treatment. This non-invasive treatment, without side effects, will benefit these patients and relieve their pain."
Mr. Nano, added, "The distribution of our device to U.S. government agencies is an important and effective step in CTT's aggressive sales and marketing program. This breakthrough device brings CTT to the forefront in providing a solution to the needs of patients and the improvement of palliative healthcare in both the U.S. and globally. The technology is a prime example of our strategy to connect clinical science to patient care. We believe that revenue and profits from the pain therapy technology will significantly increase CTT's market capitalization."
Contractual minimums for signed distribution agreements have a retail sales value of over $25 million for 2009 and about $50 million for 2010. CTT will share in revenue derived from sales of the device to distributors. Both CTT and its distributors expect sales to exceed contract minimums.
Earlier agreements granted country-exclusive distribution rights to Life Episteme srl for each of 31 countries throughout Europe, Asia, Africa, the Middle East, South America and Oceania, to Excel Life Sciences, Inc. for India, to GEOMC Co., Ltd. for Korea, to AG Healthcare for Malaysia, and to Biogene Pharma Limited for Bangladesh. The U.S. Department of Commerce estimates the world market for medical devices at $248 billion. The United States represents about half that market. In addition to 510(k) status, this medical device has CE certification from the European Union allowing European sales.
Developed in Italy by CTT's client, Prof. Giuseppe Marineo, the device was brought to CTT through the efforts of the Zangani Investor Community(tm). The device, with a biophysical rather than a biochemical approach, uses a multi-processor able to simultaneously treat multiple pain areas by applying surface electrodes to the skin. CTT partner GEOMC Co., Ltd. of Korea, is producing the device commercially for worldwide distribution. For more information on the device, visit www.CalmareTT.com.
The device has been used on over 3,000 patients in Europe, including the Pain Management Center at Tor-Vergata University Medical Center in Rome (http://www.ptvonline.it/uo_ter_ant_ing.asp).
About Competitive Technologies, Inc.
Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTT is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: www.competitivetech.net
CONTACT: IR Services, LLC
Johnnie D. Johnson
860 434 2465
jdjohnson@corpirservices.com
Provider ID: 00163615 -0- Apr/22/2009 17:12 GMT
Last Updated: April 22, 2009 13:12 EDT
Competitive Technologies Signs Agreement for Sales of Pain Therapy Medical Device
Therapy Medical Device to Selected U.S. Government Agencies
FAIRFIELD, Conn., April 22, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that it has signed an agreement with Northville, MI-based Native Energy & Economic Development LLC (Native Energy) granting them exclusive sales rights for selected U.S. Government agencies, including the Department of Veteran's Affairs (VA), the Department of Defense (DOD), and the Indian Health Service (IHS), for CTT's pain therapy medical device. The device, a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs, has FDA 510(k) status for sales in the U.S. CTT continues to review and select distributors representing other U.S. and global markets, including Europe, Asia and Latin America. CTT has exclusive worldwide rights to this device.
"Native Energy provides CTT with an established partner to reach U.S. government agencies that include the wounded warrior and the native American population in their healthcare programs," said John B. Nano, CTT's Chairman, President and CEO. "We believe that Native Energy's experience, contacts and knowledge of these important segments of the population will greatly facilitate sales of the device."
Steven J. Morello, founder of Native Energy, commented, "We welcome this opportunity to improve healthcare available to our veterans and Native Americans, by providing an alternative to harmful drug protocols for pain treatment. This non-invasive treatment, without side effects, will benefit these patients and relieve their pain."
Mr. Nano, added, "The distribution of our device to U.S. government agencies is an important and effective step in CTT's aggressive sales and marketing program. This breakthrough device brings CTT to the forefront in providing a solution to the needs of patients and the improvement of palliative healthcare in both the U.S. and globally. The technology is a prime example of our strategy to connect clinical science to patient care. We believe that revenue and profits from the pain therapy technology will significantly increase CTT's market capitalization."
Contractual minimums for signed distribution agreements have a retail sales value of over $25 million for 2009 and about $50 million for 2010. CTT will share in revenue derived from sales of the device to distributors. Both CTT and its distributors expect sales to exceed contract minimums.
Earlier agreements granted country-exclusive distribution rights to Life Episteme srl for each of 31 countries throughout Europe, Asia, Africa, the Middle East, South America and Oceania, to Excel Life Sciences, Inc. for India, to GEOMC Co., Ltd. for Korea, to AG Healthcare for Malaysia, and to Biogene Pharma Limited for Bangladesh. The U.S. Department of Commerce estimates the world market for medical devices at $248 billion. The United States represents about half that market. In addition to 510(k) status, this medical device has CE certification from the European Union allowing European sales.
Developed in Italy by CTT's client, Prof. Giuseppe Marineo, the device was brought to CTT through the efforts of the Zangani Investor Community(tm). The device, with a biophysical rather than a biochemical approach, uses a multi-processor able to simultaneously treat multiple pain areas by applying surface electrodes to the skin. CTT partner GEOMC Co., Ltd. of Korea, is producing the device commercially for worldwide distribution. For more information on the device, visit www.CalmareTT.com.
The device has been used on over 3,000 patients in Europe, including the Pain Management Center at Tor-Vergata University Medical Center in Rome (http://www.ptvonline.it/uo_ter_ant_ing.asp).
About Competitive Technologies, Inc.
Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTT is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: www.competitivetech.net
CONTACT: IR Services, LLC
Johnnie D. Johnson
860 434 2465
jdjohnson@corpirservices.com
Provider ID: 00163615 -0- Apr/22/2009 17:12 GMT
Last Updated: April 22, 2009 13:12 EDT
**CTT CONTRACT DEVICE PACT** Competitive Technologies Signs Agreement for Sales of Pain Therapy Medical Device
Therapy Medical Device to Selected U.S. Government Agencies
FAIRFIELD, Conn., April 22, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that it has signed an agreement with Northville, MI-based Native Energy & Economic Development LLC (Native Energy) granting them exclusive sales rights for selected U.S. Government agencies, including the Department of Veteran's Affairs (VA), the Department of Defense (DOD), and the Indian Health Service (IHS), for CTT's pain therapy medical device. The device, a non-invasive method for rapid treatment of high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs, has FDA 510(k) status for sales in the U.S. CTT continues to review and select distributors representing other U.S. and global markets, including Europe, Asia and Latin America. CTT has exclusive worldwide rights to this device.
"Native Energy provides CTT with an established partner to reach U.S. government agencies that include the wounded warrior and the native American population in their healthcare programs," said John B. Nano, CTT's Chairman, President and CEO. "We believe that Native Energy's experience, contacts and knowledge of these important segments of the population will greatly facilitate sales of the device."
Steven J. Morello, founder of Native Energy, commented, "We welcome this opportunity to improve healthcare available to our veterans and Native Americans, by providing an alternative to harmful drug protocols for pain treatment. This non-invasive treatment, without side effects, will benefit these patients and relieve their pain."
Mr. Nano, added, "The distribution of our device to U.S. government agencies is an important and effective step in CTT's aggressive sales and marketing program. This breakthrough device brings CTT to the forefront in providing a solution to the needs of patients and the improvement of palliative healthcare in both the U.S. and globally. The technology is a prime example of our strategy to connect clinical science to patient care. We believe that revenue and profits from the pain therapy technology will significantly increase CTT's market capitalization."
Contractual minimums for signed distribution agreements have a retail sales value of over $25 million for 2009 and about $50 million for 2010. CTT will share in revenue derived from sales of the device to distributors. Both CTT and its distributors expect sales to exceed contract minimums.
Earlier agreements granted country-exclusive distribution rights to Life Episteme srl for each of 31 countries throughout Europe, Asia, Africa, the Middle East, South America and Oceania, to Excel Life Sciences, Inc. for India, to GEOMC Co., Ltd. for Korea, to AG Healthcare for Malaysia, and to Biogene Pharma Limited for Bangladesh. The U.S. Department of Commerce estimates the world market for medical devices at $248 billion. The United States represents about half that market. In addition to 510(k) status, this medical device has CE certification from the European Union allowing European sales.
Developed in Italy by CTT's client, Prof. Giuseppe Marineo, the device was brought to CTT through the efforts of the Zangani Investor Community(tm). The device, with a biophysical rather than a biochemical approach, uses a multi-processor able to simultaneously treat multiple pain areas by applying surface electrodes to the skin. CTT partner GEOMC Co., Ltd. of Korea, is producing the device commercially for worldwide distribution. For more information on the device, visit www.CalmareTT.com.
The device has been used on over 3,000 patients in Europe, including the Pain Management Center at Tor-Vergata University Medical Center in Rome (http://www.ptvonline.it/uo_ter_ant_ing.asp).
About Competitive Technologies, Inc.
Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTT is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: www.competitivetech.net
CONTACT: IR Services, LLC
Johnnie D. Johnson
860 434 2465
jdjohnson@corpirservices.com
Provider ID: 00163615 -0- Apr/22/2009 17:12 GMT
Last Updated: April 22, 2009 13:12 EDT
thanks
picked up SIRI @ .43
SCON unloading bb $2.50 support? stopped out at $3.10
SCON explosion $3s!!!
CTT next triple bag explosion someone just bought 120k huge spike buy then the mms moved it back down on 4k shares
look at that sweet chart setup
PG raised to Buy from Neutral with $65 price tgt
SunTrust Robinson Humphrey analyst boosts Procter & Gamble rating, sees better fiscal 2010
Monday April 20, 2009, 8:35 am EDT
NEW YORK (AP) -- A SunTrust Robinson Humphrey analyst on Monday upgraded his rating on shares of consumer products company Procter & Gamble Co., saying the company should see some benefits from cutting costs in fiscal 2010.
Analyst William Chappell raised his rating to "Buy" from "Neutral" and set price target of $65, implying he expects the shares to jump 26 percent in the next 12 months.
Chappell said although Procter & Gamble will likely be challenged in the next few quarters due to the recession in the U.S. and the economic downturn in emerging markets, the company's stock "more than reflects these challenges."
The company has been hurt by consumers looking to pay less and buying more lower-priced and private label brands.
He said as investors shift their focus to fiscal 2010 -- which begins in less than three months -- the stock will likely move higher.
Chappell said the company should see "increasing benefits" from lower commodity costs and marketing expenses in the fiscal first quarter as well as easier year-over-year exchange rate and volume comparisons in the fiscal second quarter.
"In our opinion, the stock now represents an attractive entry point for patient investors," Chappell said. "Looking into fiscal 2010 we expect business trends to stabilize and for the stock to trade at more normal levels."
CTT signs contracts worth $75M
http://finance.yahoo.com/news/Competitive-Technologies-pz-14958300.html
PG nailed my $50 apr calls, flying on heavy volume
PG exploding zab coming up on $52 with huge volume no resistance at all to $54 area
increased divvy to $1.76 >> +10%
not PG >> kabooooom nailing my $50 apr calls
raised their divvy by 10% yesterday in the middle of a severe recession
PG exploding!!!!! still got $50 apr calls